CO5180624A1 - Antagonistas muscarinicos - Google Patents
Antagonistas muscarinicosInfo
- Publication number
- CO5180624A1 CO5180624A1 CO00065610A CO00065610A CO5180624A1 CO 5180624 A1 CO5180624 A1 CO 5180624A1 CO 00065610 A CO00065610 A CO 00065610A CO 00065610 A CO00065610 A CO 00065610A CO 5180624 A1 CO5180624 A1 CO 5180624A1
- Authority
- CO
- Colombia
- Prior art keywords
- muscarinic antagonists
- mfi
- jpeg
- alkoxy
- halogen
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title abstract 2
- 239000003149 muscarinic antagonist Substances 0.000 title abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- -1 1,4-disubstituted piperidine compounds Chemical class 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40139199A | 1999-09-22 | 1999-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5180624A1 true CO5180624A1 (es) | 2002-07-30 |
Family
ID=23587566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00065610A CO5180624A1 (es) | 1999-09-22 | 2000-08-31 | Antagonistas muscarinicos |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1214299B1 (enExample) |
| JP (1) | JP2003509494A (enExample) |
| CN (1) | CN1167682C (enExample) |
| AR (1) | AR025459A1 (enExample) |
| AT (1) | ATE264301T1 (enExample) |
| AU (1) | AU5786300A (enExample) |
| CA (1) | CA2384018C (enExample) |
| CO (1) | CO5180624A1 (enExample) |
| DE (1) | DE60009931T2 (enExample) |
| ES (1) | ES2215055T3 (enExample) |
| HK (1) | HK1043590A1 (enExample) |
| MX (1) | MXPA02003136A (enExample) |
| PE (1) | PE20010649A1 (enExample) |
| WO (1) | WO2001021590A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| CN1301972C (zh) * | 2001-10-10 | 2007-02-28 | 先灵公司 | 作为毒覃碱拮抗剂的哌啶化合物 |
| JPWO2004069828A1 (ja) * | 2003-02-04 | 2006-05-25 | 三菱ウェルファーマ株式会社 | ピペリジン化合物およびその医薬用途 |
| EP2533645B1 (en) | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| JP6478923B2 (ja) | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート |
| CN105142623A (zh) | 2013-03-15 | 2015-12-09 | 艾吉因生物股份有限公司 | 用于改善认知功能的方法和组合物 |
| EP2968237A4 (en) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION |
| CN107810002B (zh) | 2015-05-22 | 2021-01-05 | 艾吉因生物股份有限公司 | 左乙拉西坦的延时释放药物组合物 |
| HK1253029A1 (zh) | 2015-11-06 | 2019-06-06 | Neurocrine Biosciences, Inc. | 作为毒蕈碱性受体4(m4)拮抗剂用於治疗神经系统疾病的n-[2-(1-苄基哌啶-4-基)乙基]-4-(吡嗪-2-基)-哌嗪-1-甲酰胺衍生物及相关化合物 |
| EP4069367B1 (en) | 2019-12-06 | 2024-05-15 | Neurocrine Biosciences, Inc. | Muscarinic receptor 4 antagonists and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691323A (en) * | 1995-05-12 | 1997-11-25 | Merck & Co., Inc. | Muscarine antagonists |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| DE69919171T2 (de) * | 1998-06-30 | 2005-08-04 | Schering Corp. | Muskarin-rezeptor antagonisten |
| US6066636A (en) * | 1998-06-30 | 2000-05-23 | Schering Corporation | Muscarinic antagonists |
-
2000
- 2000-07-05 ES ES00943386T patent/ES2215055T3/es not_active Expired - Lifetime
- 2000-07-05 WO PCT/US2000/018358 patent/WO2001021590A1/en not_active Ceased
- 2000-07-05 HK HK02105117.5A patent/HK1043590A1/zh unknown
- 2000-07-05 DE DE60009931T patent/DE60009931T2/de not_active Expired - Lifetime
- 2000-07-05 CA CA002384018A patent/CA2384018C/en not_active Expired - Fee Related
- 2000-07-05 JP JP2001524970A patent/JP2003509494A/ja active Pending
- 2000-07-05 AT AT00943386T patent/ATE264301T1/de not_active IP Right Cessation
- 2000-07-05 AU AU57863/00A patent/AU5786300A/en not_active Abandoned
- 2000-07-05 CN CNB008130795A patent/CN1167682C/zh not_active Expired - Fee Related
- 2000-07-05 MX MXPA02003136A patent/MXPA02003136A/es unknown
- 2000-07-05 EP EP00943386A patent/EP1214299B1/en not_active Expired - Lifetime
- 2000-08-31 PE PE2000000890A patent/PE20010649A1/es not_active Application Discontinuation
- 2000-08-31 AR ARP000104540A patent/AR025459A1/es unknown
- 2000-08-31 CO CO00065610A patent/CO5180624A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2384018A1 (en) | 2001-03-29 |
| HK1043590A1 (zh) | 2002-09-20 |
| AR025459A1 (es) | 2002-11-27 |
| ES2215055T3 (es) | 2004-10-01 |
| AU5786300A (en) | 2001-04-24 |
| JP2003509494A (ja) | 2003-03-11 |
| EP1214299B1 (en) | 2004-04-14 |
| DE60009931T2 (de) | 2005-04-07 |
| DE60009931D1 (de) | 2004-05-19 |
| CN1374949A (zh) | 2002-10-16 |
| CA2384018C (en) | 2010-01-12 |
| ATE264301T1 (de) | 2004-04-15 |
| CN1167682C (zh) | 2004-09-22 |
| PE20010649A1 (es) | 2001-06-19 |
| WO2001021590A1 (en) | 2001-03-29 |
| EP1214299A1 (en) | 2002-06-19 |
| MXPA02003136A (es) | 2002-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2243044T3 (es) | Derivados de sulfonamida para el tratamiento de trastornos del snc. | |
| AU597188B2 (en) | 2-{(4-piperidyl)methyl}-1,2,3,4-tetrahydro-9h-pyrido{3,4-b }indole derivatives, their preparation and their application in therapy | |
| MY133992A (en) | Muscarinic antagonists | |
| NO990671D0 (no) | Muskarinantagonistiske etere | |
| YU8703A (sh) | Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1 | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| RU2007139453A (ru) | Гетеробициклические ингибиторы вируса гепатита с (hcv) | |
| NZ335733A (en) | 6-phenylpyridyl-2-amine derivatives useful as nitric oxide synthase inhibitors | |
| CO5180624A1 (es) | Antagonistas muscarinicos | |
| CA2004670A1 (en) | Anxiolytically active piperazine derivatives | |
| HUT53099A (en) | Process for producing new tetrahydrobenzimidazole derivatives and pharmaceutical compositions comprising such compounds | |
| SE9703377D0 (sv) | New compounds | |
| PT912515E (pt) | Piperidinas 1,4-di-substituidas como antagonistas muscarinicos | |
| US5929246A (en) | N-aminoalkyldibenzothiophenecarboxamides; new dopamine receptor subtype specific ligands | |
| KR960022486A (ko) | 신규 티아졸리딘-4-온 유도체 | |
| ATE429429T1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
| DE69207301T2 (de) | Substituierte 3-Piperazinylalkyl 2,3-Dihydro-4H-1,3-Benzoxazin-4-One, deren Herstellung und Verwendung in Heilkunde | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| CO5170520A1 (es) | Derivados de 4-(fenil sustituido)-2-piperazinil-pirimidin-(3,5-bistrifluoro-metil-bencil)- metil-amida | |
| MXPA02011464A (es) | Derivados 1,4-diazepan-2,5-diona y su uso como antagonistas del receptor de la nk-1. | |
| MXPA06003748A (es) | Compuestos de lactama condensada. | |
| EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
| SK99298A3 (en) | 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system | |
| DE69315363D1 (de) | Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel | |
| ECSP003642A (es) | Antagonistas muscarinicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |